MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds ...

Hologic’s HOLX Skeletal Health division has been driving positive contributions ever since the earlier supply challenges began to ease. Sales jumped 62.1% in the third quarter of fiscal 2025, driven ...

Hologic HOLX is set to release fourth-quarter fiscal 2025 results on Nov. 3, after the closing bell. The Zacks Consensus Estimate for fiscal fourth-quarter earnings per share (EPS) suggests an 8.9% ...

Medical technology company Hologic (NASDAQ:HOLX) reported Q2 CY2025 results , with sales up 1.2% year on year to $1.02 billion. The company expects next quarter’s revenue to be around $1.04 billion, ...

Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...

Medical technology company Hologic (NASDAQ:HOLX) announced in Q3 CY2025, with sales up 6.2% year on year to $1.05 billion. Its non-GAAP profit of $1.13 per share was 2.7% above analysts’ consensus ...

Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue Milestones Represents 46% Premium to Hologic’s Closing ...